SHL Telemedicine Ltd. (SHLT)
NASDAQ: SHLT
· Real-Time Price · USD
2.05
0.00 (0.00%)
At close: Apr 02, 2025, 10:51 AM
SHL Telemedicine Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 55.94M | 70.72M | 71.28M | 85.2M | 85.21M | 87.27M | 88.22M | 74.55M | 74.77M | 54.52M | 49.58M | 56.15M | 52.21M | 61.29M |
Cost of Revenue | 30.36M | 39.04M | 39.76M | 47.68M | 47.79M | 47.67M | 47.56M | 39.28M | 38.8M | 27.93M | 24.99M | 27.51M | 25.02M | 29.66M |
Gross Profit | 25.58M | 31.68M | 31.52M | 37.51M | 37.42M | 39.6M | 40.66M | 35.27M | 35.97M | 26.59M | 24.59M | 28.63M | 27.19M | 31.64M |
Operating Income | -7.86M | -9.78M | -10.04M | -11.57M | -11.98M | -9.02M | -7.31M | -3.34M | -1.09M | -234K | 211K | -4.37K | -154.37K | 905.62K |
Interest Income | 3.28M | 7.69M | 9.21M | 13.89M | 13.22M | 9.47M | 8.62M | 7.02M | 10.77M | 14.9M | 19.02M | 14.35M | 9.68M | 4.99M |
Pretax Income | -7.97M | -7.66M | -6.66M | -3.39M | -622.63K | 1.09M | 1.96M | -902.81K | -3.28M | -8.45M | -13.47M | -11.71M | -9.89M | -4.84M |
Net Income | -8.84M | -9.03M | -8.14M | -5.82M | -3.45M | -1.23M | -113.55K | -1.93M | -3.79M | -8.96M | -14.11M | -11.98M | -9.97M | -4.76M |
Selling & General & Admin | 26.5M | 33.67M | 33.82M | 41.54M | 42.32M | 42.2M | 42.09M | 34.31M | 33.47M | 24.02M | 21.56M | 24.86M | 23.38M | 26.35M |
Research & Development | 5.47M | 6.53M | 6.43M | 7.06M | 6.66M | 6M | 5.66M | 4.24M | 3.85M | 2.99M | 2.98M | 3.78M | 3.86M | 4.36M |
Other Expenses | 1.04M | 1.04M | 834.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 32.42M | 40.44M | 40.54M | 48.06M | 45.86M | 45.08M | 44.42M | 41.83M | 50.59M | 40.35M | 37.91M | 35.4M | 27.37M | 30.76M |
Interest Expense | n/a | 1.41M | 1.41M | 2.61M | 2.61M | 1.2M | 1.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 10.54M | 10.56M | 10.58M | 11.21M | 11.84M | 11.62M | 11.4M | 10.83M | 10.25M | 9.85M | 9.45M | 8.88M | 8.3M | 8.03M |
Cost & Expenses | 62.78M | 79.47M | 80.31M | 95.74M | 93.65M | 92.75M | 91.98M | 81.11M | 89.39M | 68.28M | 62.9M | 62.91M | 52.39M | 60.42M |
Income Tax Expense | 650K | 1.12M | 1.24M | 1.98M | 2.31M | 1.87M | 1.64M | 854.97K | 487.96K | 520K | 677K | 293.86K | 400.86K | 242.54K |
Shares Outstanding (Basic) | 16.67M | 16.67M | 12.21M | 12.21M | 15.84M | 15.84M | 14.54M | 14.53M | 14.52M | 14.52M | 14.15M | 14.38M | 13.71M | 13.71M |
Shares Outstanding (Diluted) | 16.67M | 16.67M | 16.7M | 16.7M | 15.84M | 15.84M | 14.54M | 14.68M | 14.52M | 14.52M | 14.38M | 14.38M | 13.71M | 13.71M |
EPS (Basic) | -0.64 | -0.66 | -0.61 | -0.42 | -0.22 | -0.08 | -0.01 | -0.14 | -0.27 | -0.65 | -1.03 | -0.87 | -0.73 | -0.35 |
EPS (Diluted) | -0.52 | -0.54 | -0.49 | -0.36 | -0.22 | -0.08 | -0.01 | -0.13 | -0.26 | -0.64 | -1.02 | -0.87 | -0.73 | -0.35 |
EBITDA | -1.96M | 1.64M | 1.27M | 8.23M | 7.86M | 9.23M | 10.9M | 7.15M | 9.09M | 5.29M | 5.15M | 5.83M | 5.7M | 7.51M |
EBIT | -9.78M | -10.05M | -10.31M | -8.19M | -8.6M | -6.88M | -5.17M | -2.92M | -679K | -234K | 211K | 278.91K | 128.91K | 680.1K |
Depreciation & Amortization | 5.29M | 6.91M | 6.8M | 9.91M | 9.96M | 9.88M | 9.83M | 8.1M | 7.8M | 5.52M | 4.94M | 5.56M | 5.58M | 6.83M |